Potent, highly specific non-ATP-competitive inhibitor of MEK (aka MKK) 1/2; a derivative of PD184352 (Axon 1368) to improve bioavailability; clinical candidate and highly recommended tool to inhibit MKK1 or MKK1 plus MKK5 in cells.
* PD0325901 and CHIR99021 (Axon 1386) from Axon Medchem are often used together as perfect 2i in stem cell research (Axon 2128).

*Promotion: PD 0325901 is also part of Inhibitor Set(s):

Prime Source Information:
PD0325901 from Axon Medchem has been procured by many labs as drug standard for generating reliable and reproducible biological data, evidenced by many recent publications.

KEYWORDS: PD0325901 | supplier | MEK1 inhibitor | Mirdametinib | PD-0325901 | PD 0325901 | PD325901 | PD-325901 | PD 325901 | CAS [391210-10-9] | MAPK | MEK1 | MEK2 | Inhibitor | MKK | MKK1 | stem cell | pluripotent | renewel | DNA | lesion